Related Experiment Video
Updated: Oct 9, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
Iron in Cardiovascular Disease: Challenges and Potentials
1Department of Geriatrics, The Second Xiangya Hospital, Central South University, Changsha, China.
Insights
Iron
Area of Science:
- Cardiovascular Research
- Cell Death Mechanisms
- Mineral Metabolism
Background:
- Iron is vital for biological functions, but imbalances cause disease.
- Iron's role in cardiovascular disease (CVD) is complex and not fully understood.
- Ferroptosis, an iron-dependent cell death, is implicated in various CVDs.
Purpose of the Study:
- To review the pathological roles of iron in cardiovascular diseases.
- To highlight ferroptosis as a key mechanism in iron-related CVD.
- To discuss iron chelation therapy for cardiovascular conditions.
Main Methods:
- Literature review and synthesis of existing research on iron metabolism and CVD.
- Analysis of studies investigating ferroptosis in cardiovascular conditions.
- Evaluation of therapeutic strategies targeting iron overload.
Main Results:
- Iron deficiency negatively impacts heart failure and pulmonary arterial hypertension.
- Ferroptosis is observed in cardiomyopathy, atherosclerosis, and ischemia/reperfusion injury.
- Iron chelation shows potential for treating iron overload disorders.
Conclusions:
- Clarifying iron's precise role in CVD is crucial for developing effective treatments.
- Targeting ferroptosis may offer novel therapeutic avenues for cardiovascular diseases.
- Further research is needed to optimize iron-related interventions in CVD.
Abstract:
Iron is essential for many biological processes. Inadequate or excess amount of body iron can result in various pathological consequences. The pathological roles of iron in cardiovascular disease (CVD) have been intensively studied for decades. Convincing data demonstrated a detrimental effect of iron deficiency in patients with heart failure and pulmonary arterial hypertension, but it remains unclear for the pathological roles of iron in other cardiovascular diseases. Meanwhile, ferroptosis is an iron-dependent cell death that is distinct from apoptosis, necroptosis, and other types of cell death. Ferroptosis has been reported in several CVDs, namely, cardiomyopathy, atherosclerotic cardiovascular disease, and myocardial ischemia/reperfusion injury. Iron chelation therapy seems to be an available strategy to ameliorate iron overload-related disorders. It is still a challenge to accurately clarify the pathological roles of iron in CVD and search for effective medical intervention. In this review, we aim to summarize the pathological roles of iron in CVD, and especially highlight the potential mechanism of ferroptosis in these diseases.
Related Concept Videos
Coronary Artery Disease I: Introduction
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pathophysiology of Cardiac Performance
Atherosclerosis III: Management

